Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Teva Pharma Industries Ltd ADR (TEVA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Teva ADR's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
13.25 +0.24    +1.84%
25/04 - Closed. Currency in USD ( Disclaimer )
Pre Market
13.19
-0.06
-0.45%
8:40:32 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 8,470,173
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 12.77 - 13.30
Teva ADR 13.25 +0.24 +1.84%

TEVA User Rankings

 
Users ranking according to the performance of their sentiments for the Teva Pharma Industries Ltd ADR stock.
RankUsernameTotalClosedWinningWin %Chg. %
1eli shwartz1716850+216.39%
2Ilan Aviram55480+194.45%
3Tony Serra1010550+176.01%
4Sharon Tsi-on21201050+169.4%
5Clement Coenen222100+134.55%
6Gil Sherer33266.67+123.17%
7Thomas Pfister222100+119.11%
8rafi toledano333100+119.09%
9Ирина Ступина222100+117.71%
10Venancio Litico55480+116.66%
11Aharon Barel333100+113.56%
12Av8er3133266.67+112.78%
13Anna Sokolidou222100+111.63%
14Steen Lyth222100+111.44%
15Nikolaos Englezopoulos1616850+111.01%
16sam segev33266.67+109.86%
17Anders Joendrup111100+108.78%
18ricardo vieira111100+107.52%
19Daniel Haimov33266.67+107.13%
20Preben Secher1211436.36+105.94%
21עמוס קוק66466.67+105.57%
22병욱 강111100+104.09%
23ערן גרפינקל111100+100%
24Tomas Sakalauskas22150+99.47%
25Baruch Machluf111100+97.57%
26Yaniv Babayoff111100+97.07%
27Brian Marjø1212758.33+97.04%
28רועי בי33266.67+95.9%
29Александр Вяльцев222100+94.93%
30Sagiv Moalem66466.67+94.1%
31Kristina Ostrovsky44375+93.31%
324trader88450+92.43%
33MrLearner55480+92.11%
34עדן מאמן אישי111100+91.34%
35YEHUDA CHEN22150+88.59%
36חגי חורש33266.67+88.5%
37אברהם עמר222100+88.38%
38Johan Matras222100+87.51%
39שרון ציוני222100+86.64%
40Oren Mizrahi111100+85.48%
41edgar blumenthal111100+85.48%
42lee sangmin111100+84.93%
43Justo De La Nuez22150+82.94%
44Alon Nahum333100+82.71%
45Martin Poulsen111100+82.42%
46amir tuviana66350+80.18%
47Eric Garneau333100+80.13%
48Erik Esparza33266.67+80.08%
49ulrik schultz111100+79.14%
50Евгений Корсаков222100+78.94%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TEVA Comments

Write your thoughts about Teva Pharma Industries Ltd ADR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
TSahi Livnoni
TSahi Livnoni Apr 11, 2024 8:56AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Teva Confirms Efficacy and Safety of AJOVY® (fremanezumab) for the Prevention of Migraine With Results from Phase 3 Trial in China
TSahi Livnoni
TSahi Livnoni Apr 11, 2024 8:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Teva Confirms Efficacy and Safety of AJOVY® (fremanezumab) for the Prevention of Migraine With Results from Phase 3 Trial in China April 11, 2024 8:30 AM AJOVY confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month All critical efficacy endpoints met significance as set out apriori through hierarchical testing AJOVY confirmed a favorable safety profile
TSahi Livnoni
TSahi Livnoni Apr 11, 2024 8:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Teva Confirms Efficacy and Safety of AJOVY® (fremanezumab) for the Prevention of Migraine With Results from Phase 3 Trial in China April 11, 2024 8:30 AM AJOVY confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month All critical efficacy endpoints met significance as set out apriori through hierarchical testing AJOVY confirmed a favorable safety profile
TSahi Livnoni
TSahi Livnoni Mar 23, 2024 9:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
1% on a Friday with 9.13M volume someone is buying.
TSahi Livnoni
TSahi Livnoni Mar 13, 2024 10:16AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
simple story of debt reduction and value going up. revenue growth will set the pace will move up in the next 2-3 years to about 30-40$
ritchie lee
ritchie lee Jan 22, 2024 1:49PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
long trend starting
Ramba Łej
Kubizm Jan 22, 2024 1:49PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hopefully ! Ive been w8ing for it for 3 y xD
Ramba Łej
Kubizm Sep 14, 2023 10:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
11,40 will hold as celling or convert to floor :)?
Ramba Łej
Kubizm Aug 02, 2023 8:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
looking good on pre-market. Wonder how USA downgrade might spoil the fun here
BumHunters Archer
JohnJenga Aug 02, 2023 8:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
25 next year seems quite doable
Michael Christensen
Michael Christensen Aug 02, 2023 6:00AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Somebody know the consensus for Q2 today ?
Harel Cohen
Harel Cohen Aug 01, 2023 10:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
first real report of new CEO... it will be interesting
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email